Literature DB >> 17516514

Mutation in G6PD gene leads to loss of cellular control of protein glutathionylation: mechanism and implication.

Iraimoudi S Ayene1, John E Biaglow, Alexander V Kachur, Thomas D Stamato, Cameron J Koch.   

Abstract

More than 400 million people are susceptible to oxidative stress due to glucose-6-phosphate dehydrogenase (G6PD) deficiency. Protein glutathionylation is believed to be responsible for loss of protein function and/or cellular signaling during oxidative stress. To elucidate the implications of G6PD deficiency specifically in cellular control of protein glutathionylation, we used hydroxyethyldisulfide (HEDS), an oxidant which undergoes disulfide exchange with existing thiols. G6PD deficient (E89) cells treated with HEDS showed a significant increase in protein glutathionylation compared to wild-type (K1) cells. In order to determine whether increase in global protein glutathionylation by HEDS leads to loss of function of an important protein, we compared the effect of HEDS on global protein glutathionylation with that of Ku protein function, a multifunctional DNA repair protein, using a novel ELISA. E89 cells treated with HEDS showed a significant loss of Ku protein binding to DNA. Cellular protein thiol and GSH, whose disulfide is involved in protein glutathionylation, were decreased by HEDS in E89 cells with no significant effect in K1 cells. E89 cells showed lower detoxification of HEDS, that is, conversion of disulfide HEDS to free sulfhydryl mercaptoethanol (ME), compared to K1 cells. K1 cells maintained their NADH level in the presence of HEDS but that of E89 cells decreased by tenfold following a similar exposure. NADPH, a cofactor required to maintain reduced form of the thiols, was decreased more in E89 than K1 cells. The specific role of G6PD in the control of such global protein glutathionylation and Ku function was further demonstrated by reintroducing the G6PD gene into E89 (A1A) cells, which showed a normal phenotype. Copyright (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 17516514     DOI: 10.1002/jcb.21394

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  8 in total

1.  Hydroxyethyl disulfide as an efficient metabolic assay for cell viability in vitro.

Authors:  Jie Li; Donglan Zhang; Kathleen M Ward; George C Prendergast; Iraimoudi S Ayene
Journal:  Toxicol In Vitro       Date:  2012-01-31       Impact factor: 3.500

2.  pO(2)-dependent NO production determines OPPC activity in macrophages.

Authors:  Mary A Robinson; Stephen W Tuttle; Cynthia M Otto; Cameron J Koch
Journal:  Free Radic Biol Med       Date:  2009-10-12       Impact factor: 7.376

3.  A bioactive probe of the oxidative pentose phosphate cycle: novel strategy to reverse radioresistance in glucose deprived human colon cancer cells.

Authors:  Jie Li; Kathleen M Ward; Donglan Zhang; Eswarkumar Dayanandam; Albert S Denittis; George C Prendergast; Iraimoudi S Ayene
Journal:  Toxicol In Vitro       Date:  2012-08-16       Impact factor: 3.500

4.  Glucose deprivation increases nuclear DNA repair protein Ku and resistance to radiation induced oxidative stress in human cancer cells.

Authors:  Jie Li; Roashan Ayene; Kathleen M Ward; Eswarkumar Dayanandam; Iraimoudi S Ayene
Journal:  Cell Biochem Funct       Date:  2009-03       Impact factor: 3.685

5.  A bioactive probe for glutathione-dependent antioxidant capacity in breast cancer patients: implications in measuring biological effects of arsenic compounds.

Authors:  Jie Li; Donglan Zhang; Pearl A Jefferson; Kathleen M Ward; Iraimoudi S Ayene
Journal:  J Pharmacol Toxicol Methods       Date:  2013-10-20       Impact factor: 1.950

Review 6.  Molecular mechanisms and clinical implications of reversible protein S-glutathionylation.

Authors:  John J Mieyal; Molly M Gallogly; Suparna Qanungo; Elizabeth A Sabens; Melissa D Shelton
Journal:  Antioxid Redox Signal       Date:  2008-11       Impact factor: 8.401

Review 7.  Reduced glutathione: a radioprotector or a modulator of DNA-repair activity?

Authors:  Anupam Chatterjee
Journal:  Nutrients       Date:  2013-02-07       Impact factor: 5.717

8.  Antimetabolite TTL-315 selectively kills glucose-deprived cancer cells and enhances responses to cytotoxic chemotherapy in preclinical models of cancer.

Authors:  James DuHadaway; George C Prendergast
Journal:  Oncotarget       Date:  2016-02-16
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.